Anzeige
Mehr »
Login
Dienstag, 21.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
STRONG BUY! Kurs eskaliert - A Star is Born!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A4010U | ISIN: CA45829L1076 | Ticker-Symbol: ZK9
Frankfurt
21.01.25
08:01 Uhr
0,318 Euro
-0,002
-0,62 %
Branche
Rohstoffe
Aktienmarkt
Sonstige
1-Jahres-Chart
INTEGRAL METALS CORP Chart 1 Jahr
5-Tage-Chart
INTEGRAL METALS CORP 5-Tage-Chart
GlobeNewswire (Europe)
100 Leser
Artikel bewerten:
(0)

Integral Metals Corp. Announces Listing on the Frankfurt Stock Exchange

Finanznachrichten News

CALGARY, Alberta, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | FSE: ZK9) (the "Company" or "Integral") is pleased to announce its common shares are now trading on the Frankfurt Stock Exchange ("FSE") under the symbol "ZK9", WKN: A4010U, and ISIN: CA 45829L1076.

The Company's common shares are now dual listed on the Canadian Stock Exchange (CSE) and the FSE, offering increased international exposure to both Canadian and European investors. This dual listing also enhances liquidity for the Company's shareholders. The Company's FSE stock quote can be accessed here: https://www.boerse-frankfurt.de/equity/integral-metals-corp.

Integral Metals CEO, Paul Sparkes, commented, "We are excited to be listed on one of the world's leading trading markets. This dual listing not only broadens our international exposure but also provides enhanced liquidity and access for our shareholders in both Canada and Europe. We look forward to engaging with a wider investor base as we continue to drive value for our stakeholders."

On Behalf of the Board Directors

Paul Sparkes

Chief Executive Officer

825-414-3163

info@integralmetals.com

ABOUT INTEGRAL METALS CORP.

Integral is an exploration stage company, engaged in the business of mineral exploration for critical minerals, including gallium and germanium, with the goal of contributing to the development of a domestic supply chain for these minerals. Integral holds properties in mining-friendly jurisdictions in Canada, including the Northwest Territories and Manitoba, where it has received regulatory support for its exploration efforts. The Company is currently focused on the exploration of its material property, the Kap Property, which is comprised of six contiguous claims located in the Northwest Territories.

The CSE and Information Service Provider have not reviewed and do not accept responsibility for the accuracy or adequacy of this release.

Forward-Looking Information

Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current beliefs or assumptions as to the outcome and timing of such future events. In particular, this press release contains forward-looking information relating to, among other things, the Company's future plans, including the Company's plans to focus its efforts and resources on the Kap Property and its other mineral properties.

Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information, including, in respect of the forward-looking information included in this press release, assumptions regarding the future plans and strategies of the Company, including that the Company will continue to focus its efforts and resources on the Kap Property.

Although forward-looking information is based on the reasonable assumptions of the Company's management, there can be no assurance that any forward-looking information will prove to be accurate. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. Such factors include, among other things, the risk that the Company's business prospects and priorities may change, whether as a result of unexpected events, general market and economic conditions or as a result of the Company's future exploration efforts, and that any such change may result in a re-deployment of the Company's resources and efforts in a manner divergent from the Company's current business plan or strategy. The forward-looking information contained in this release is made as of the date hereof, and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.


© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.